|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | FoxHollow Technologies (NASDAQ: FOXH ), a developer of minimally invasive plaque excision devices for the treatment of peripheral artery disease. |
|---|---|
| Transferring Party | Kerberos Proximal Solutions, Inc., a privately-held developer of innovative medical devices for the removal of thrombus, or blood clots, from occluded arteries. |
| Sector | Medical Devices |
| Date | August 29, 2006 |
| Analysis Kerberos' Thrombectomy aspiration device will expand FoxHollow's product line to combat arterial disease and will be sold via FoxHollow's 200-plus person sales and marketing team. Deal value - $32m, plus earnouts. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |